An individual approach.
Lewis
Ricki
R
D000483:Alleles; D019295:Computational Biology; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends*; D004651:Employment / Q000639:trends; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D020411:Oligonucleotide Array Sequence Analysis; D010597:Pharmacogenetics / Q000193:education / Q000639:trends*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D013450:Sulfones / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration; D000078329:Workforce
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib